Medical Diagnostic Laboratories, L.L.C., Fights Tick- and Mosquito-borne Epidemic with New Comprehensive Testing for Vector-borne Disease.
Genesis Drug Discovery & Development Announces Operating Agreement with Ophthy-DS, Inc.
Genesis Biotechnology Group announces partnership with Yale University
Genesis Drug Discovery & Development Appoints Olesia Buiakova, M.D., Ph.D., as Chief Scientific Officer
Abstract accepted for Presentation at The Association for Research in Vision and Ophthalmology (ARVO) 2018 Annual Meeting April 29 – May 03, 2018 in Honolulu, Hawaii
Invivotek Maintains Full AAALAC Accreditation for Excellence in Animal Care and Use
Genesis Biotechnology Group® Acquires Assets of 4path, Ltd to Expand their Diagnostic Branch
Invivotek Completes Solar Farm and Facility Expansion
Genesis Biotechnology Group Expands Preclinical Contract Research Portfolio by Acquiring PharmOptima
Mercer County Community College has launched a partnership with GBG to give students the opportunity to work while they learn
Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Test
Medical Diagnostic Laboratories, L.L.C.’s The Institute for Biomarker Research Announces New Prenatal Cystic Fibrosis Tests
Invivotek is Awarded Full AAALAC Accreditation for Excellence in Animal Care and Use
Biotech Company Sponsors International Bacterial Vaginosis Symposium to Continue Support of Women’s Health
Mercer Regional Chamber of Commerce 2011 Award
Announcing new testing for Aerobic Vaginitis (AV).
A Complimentary Reflex Test to Determine Metronidazole Resistance in Trichomonas vaginalis.
New Bacterial Vaginosis/Lactobacillus Profiling Assay
New HPV-16 Status Test
If you have any questions or technical issues with the application, please contact us at email@example.com for assistance.